|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
DE4006630A1
(de)
|
1990-03-03 |
1991-09-12 |
Behringwerke Ag |
Humane monoklonale antikoerper gegen tollwutviren, ihre herstellung und verwendung
|
|
US5512421A
(en)
|
1991-02-19 |
1996-04-30 |
The Regents Of The University Of California |
Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
|
|
EP0796657B1
(en)
|
1991-06-21 |
2002-01-16 |
Phillips Petroleum Company |
Alkylation catalyst containing hydrofluoric acid and a sulfone
|
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
|
US5866552A
(en)
|
1996-09-06 |
1999-02-02 |
The Trustees Of The University Of Pennsylvania |
Method for expressing a gene in the absence of an immune response
|
|
PT904392E
(pt)
|
1996-10-17 |
2001-06-29 |
Oxford Biomedica Ltd |
Vectores retrovirais
|
|
GB9720465D0
(en)
|
1997-09-25 |
1997-11-26 |
Oxford Biomedica Ltd |
Dual-virus vectors
|
|
GB9803351D0
(en)
|
1998-02-17 |
1998-04-15 |
Oxford Biomedica Ltd |
Anti-viral vectors
|
|
DE69941049D1
(de)
|
1998-05-22 |
2009-08-13 |
Oxford Biomedica Ltd |
Retrovirales verabreichungssystem
|
|
GB9904905D0
(en)
|
1999-03-03 |
1999-04-28 |
Oxford Biomedica Ltd |
Cells
|
|
JP2003504541A
(ja)
|
1999-07-13 |
2003-02-04 |
ペリセル カルロス フラデラ |
建築パネル及びその製造設備
|
|
GB0009760D0
(en)
|
2000-04-19 |
2000-06-07 |
Oxford Biomedica Ltd |
Method
|
|
GB0024550D0
(enExample)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
US6723551B2
(en)
|
2001-11-09 |
2004-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
|
SI1504108T1
(sl)
|
2002-02-01 |
2013-07-31 |
Oxford Biomedica (Uk) Limited |
Lentiviralni vektor
|
|
SE0302509D0
(sv)
|
2003-09-19 |
2003-09-19 |
Amersham Biosciences Ab |
Matrix for separation of polyethers and method of separation
|
|
US7943374B2
(en)
|
2005-08-21 |
2011-05-17 |
Markus Hildinger |
Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb
|
|
GB0526210D0
(en)
|
2005-12-22 |
2006-02-01 |
Oxford Biomedica Ltd |
Vectors
|
|
GB0526211D0
(en)
|
2005-12-22 |
2006-02-01 |
Oxford Biomedica Ltd |
Viral vectors
|
|
US20090214478A1
(en)
|
2008-02-21 |
2009-08-27 |
Alberto Auricchio |
Method of treating ocular diseases by gene therapy
|
|
DK2307551T3
(en)
|
2008-06-18 |
2017-03-20 |
Oxford Biomedica (Uk) Ltd |
CLEANING RETROVIRAL VECTORS
|
|
WO2011148194A1
(en)
*
|
2010-05-28 |
2011-12-01 |
Oxford Biomedica (Uk) Ltd |
Delivery of lentiviral vectors to the brain
|
|
GB201118636D0
(en)
*
|
2011-10-28 |
2011-12-07 |
Oxford Biomedica Ltd |
Nucleotide sequence
|
|
US10400252B2
(en)
*
|
2011-10-28 |
2019-09-03 |
Oxford Biomedica (Uk) Ltd. |
Catecholamine enzyme fusions
|
|
CN116024271A
(zh)
*
|
2018-05-31 |
2023-04-28 |
康霖生物科技（杭州）有限公司 |
一种用于中枢神经系统疾病治疗的基因序列构建体
|